Shengxia Z. Yin - Publications

Age-associated impairment of humoral and cellular immune responses to SARS-CoV-2 in a large community cohort with hybrid immunity.

Journal: The Journal of infection

Published: March 13, 2026

Age-associated differences in XBB.1.5 trivalent booster vaccine-induced adaptive responses revealed by single-cell RNA sequencing.

Journal: Emerging microbes & infections

Published: February 03, 2026

Single-cell RNA sequencing reveals mucosal BPIFA1-high-expressing neutrophils aid immune defense in SARS-CoV-2 breakthrough infection.

Journal: The Journal of infectious diseases

Published: December 24, 2025

Activated circulating T follicular helper 17 cells positively correlated with anti-HBV humoral immunity in chronic hepatitis B patients.

Journal: Frontiers in microbiology

Published: September 18, 2025

Incidence and determinants of achieving HBsAg <100 IU/mL in HBeAg-negative CHB patients with nucleos(t)ide analogue treatment.

Journal: Emerging microbes & infections

Published: September 17, 2025

Association between serum HBV DNA levels and liver fibrosis in chronic hepatitis B.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 08, 2025

Antiviral Therapy Reduces Hepatocellular Carcinoma and Cirrhosis Risk in Chinese Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 29, 2025

Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody.

Journal: Virulence

Published: July 20, 2025

Clinical Characteristics of Indeterminate Chronic Hepatitis B Patients With and Without Liver Biopsy.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: July 15, 2025

Nuclear Factor I-B Delays Liver Fibrosis by Inhibiting Chemokine Ligand 5 Transcription.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 18, 2025

B cells in metabolic dysfunction-associated steatotic liver disease (MASLD): From mechanisms to therapeutic exploration.

Journal: International immunopharmacology

Published: April 07, 2025

Extreme gradient boosting-based explainable machine learning model for predicting significant fibrosis in autoimmune hepatitis.

Journal: QJM : monthly journal of the Association of Physicians

Published: April 06, 2025